ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00793234
Recruitment Status : Completed
First Posted : November 19, 2008
Last Update Posted : April 7, 2014
Sponsor:
Collaborators:
BioInvent International AB
Covance
Information provided by (Responsible Party):
ThromboGenics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2010
  Actual Study Completion Date : March 2010